Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2005
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272764 Imidazopyridine compound
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272754 Polymorphic forms of rifaximin, processes for their production and uses thereof
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
12/08/2005US20050272701 Pharmaceutical composition
12/08/2005US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/08/2005US20050272132 For therapy of a fungal infection
12/08/2005US20050272119 Polypeptides having 2',5'-oligoadenylate phosphodiesterase activity, antibodies against polypeptides, polynucleotides coding for polypeptides, recombinant plasmid DNAs into which polynucleotides have been inserted; for searching for antitumor agents, viricides
12/08/2005US20050272091 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
12/08/2005US20050271758 Topical compositions containing Bacillus coagulans extracellular products and uses thereof
12/08/2005US20050271750 Topical formulation for prevention and treatment of acne
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005US20050271690 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
12/08/2005US20050271687 Retrovirus-like particles made non-infectious by a plurality of mutations
12/08/2005US20050271681 Isolated FrpB nucleic acid molecule and vaccine
12/08/2005US20050271680 Using immunogenic proteins LigA and LigB from Leptospira in development of effective vaccines and antibodies; detection of pathogenic Leptospira infection in a mammal
12/08/2005US20050271678 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
12/08/2005US20050271677 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins
12/08/2005US20050271652 Treatment of pathologies which escape the immune response, using optimised antibodies
12/08/2005US20050271604 Matrix protein compositions for wound healing
12/08/2005US20050268908 Medicament dispenser
12/08/2005DE19932216B4 Teilchen, insbesondere Mikroteilchen oder Nanoteilchen, aus vernetzten Monosacchariden und Oligosacchariden, Verfahren zu deren Herstellung und Verwendung der Teilchen als kosmetisches Mittel oder zur Herstellung pharmazeutischer Zusammensetzungen oder Nahrungsmittelzusammensetzungen Particles, in particular microparticles or nanoparticles of crosslinked monosaccharides and oligosaccharides, a process for their preparation and use of the particles as a cosmetic agent or for the preparation of pharmaceutical compositions or food compositions
12/08/2005DE19930557B4 Verfahren zur Herstellung von Hydraten von Ciprofloxacin und von Ciprofloxacin-Anhydrat enthaltenden pharmazeutischen Zusammensetzungen Process for the preparation of hydrates of ciprofloxacin and of ciprofloxacin containing pharmaceutical compositions anhydrate
12/08/2005CA2822895A1 Influenza hemagglutinin and neuraminidase variants
12/08/2005CA2772033A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2772029A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2577415A1 Enhancement of antitubercular activity of extracts of salicornia brachiata
12/08/2005CA2567929A1 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
12/08/2005CA2567457A1 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
12/08/2005CA2567454A1 3-[4-(6-{4,5-dihydroisoxazol-3-yl}pyridin-3-yl)-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
12/08/2005CA2566963A1 3-[4-{6-substituted alkanoyl pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
12/08/2005CA2565259A1 Soluble lfa-3 polypeptide for treating viral disorders
12/07/2005EP1602380A1 Preventive/remedy for diseases in upper digestive tract
12/07/2005EP1602378A1 Method for administering a cytokine to the central nervous system and the lymphatic system
12/07/2005EP1602375A2 Administration of products of the 5-lipoxygenase pathway for treating microbial infections
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601769A1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism
12/07/2005EP1601768A2 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide
12/07/2005EP1601685A1 Hepatitis c inhibiting compounds
12/07/2005EP1601376A1 Use of myxoma virus for therapeutic treatment of cancer and chronic viral infection
12/07/2005EP1601368A2 Methods and compositions for treatment of viral diseases
12/07/2005EP1601328A2 Polyvalent immunogen
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1463408A4 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
12/07/2005EP1439840B1 Monobactam antibacterial compounds and methods of use thereof
12/07/2005EP1389207B1 Polymorphic and other crystalline forms of cis-ftc
12/07/2005EP1385886B1 Method for preparing human immunoglobulin concentrates for therapeutic use
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP1326608B1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1301191B1 Potent immunostimulants from microalgae
12/07/2005EP1294717B1 A thiazine oxazolidinone
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP1221852B1 Therapeutic use of antimicrobial compositions comprising a benzoic acid analog and a metal salt
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1165094B1 Dispersible macrolide compounds and method for the production thereof
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1079809B1 Enteric coated pharmaceutical composition and method of manufacturing
12/07/2005EP1071412B1 Use of quinolinate for treating gastrointestinal disorders
12/07/2005EP1064263B1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection
12/07/2005EP0998568B1 Mutant having uracil phosphoribosyl transferase activity
12/07/2005EP0996717B1 Immunoprotective influenza antigen and its use in vaccination
12/07/2005EP0831901B2 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
12/07/2005EP0794794B1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
12/07/2005EP0738328B1 Composition containing nucleic acids, preparation and uses
12/07/2005CN1705678A Therapeutic peptides
12/07/2005CN1705670A 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
12/07/2005CN1705488A Dengue virus infection inhibitor
12/07/2005CN1705487A Carbohydrate based anti-bacterials
12/07/2005CN1705478A Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/07/2005CN1704417A Novel curcumenol derivatives
12/07/2005CN1704406A Intermediate for the preparation of epimino
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1704401A Pharmaceutical use of 1-N-methoxy-2-oxo-indole-3-acetamide
12/07/2005CN1704114A Synergistic antiplaque antigingivitis oral composition
12/07/2005CN1230538C Immunological reagent specifically interreacting with the extracellular domain of the human zeta chain
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230444C Use of HIV polypeptide or peptide or polynucleotide expression construct containing HIV-cell toxicant T-lymphocyte epitope
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230202C External coated chewing gum products
12/07/2005CN1230198C Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having G chronic hepatitis C infection
12/07/2005CN1230194C Medicine for preventing and treating deficiency-cold and its preparation
12/07/2005CN1230180C External medicine for killing and inhibiting fungus
12/07/2005CN1230177C Water solution of penciclovir, and its prepn. method
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/07/2005CN1230156C Fibrauretine dispersant tablet and its preparing method
12/07/2005CN1230150C Slow release pharmaceutical compositions comprising lithium carbonate
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
12/06/2005US6972286 Oxazolidinones having a benzannulated 6- or 7-membered heterocycle
12/06/2005US6972171 mixing polynucleotides with folic acid, hormones, peptides, glycoproteins, lipids or phosphatides to form nucleotides used as drugs; genetic engineering; gene expression
1 ... 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 ... 1798